Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 22;10(11):e31624.
doi: 10.1016/j.heliyon.2024.e31624. eCollection 2024 Jun 15.

Genetic variability of FOXP2 and its targets CNTNAP2 and PRNP in frontotemporal dementia: A pilot study in a southern Italian population

Paolina Crocco  1 , Francesco De Rango  1 , Francesco Bruno  2 , Antonio Malvaso  3 , Raffaele Maletta  2 , Amalia C Bruni  2 , Giuseppe Passarino  1 , Giuseppina Rose  1 , Serena Dato  1
Affiliations

Genetic variability of FOXP2 and its targets CNTNAP2 and PRNP in frontotemporal dementia: A pilot study in a southern Italian population

Paolina Crocco et al. Heliyon. .

Abstract

The Forkhead box P2 (FOXP2) is an evolutionary conserved transcription factor involved in the maintenance of neuronal networks, implicated in language disorders. Some evidence suggests a possible link between FOXP2 genetic variability and frontotemporal dementia (FTD) pathology and related endophenotypes. To shed light on this issue, we analysed the association between single-nucleotide polymorphisms (SNPs) in FOXP2 and FTD in 113 patients and 223 healthy controls. In addition, we investigated SNPs in two putative targets of FOXP2, CNTNAP2, Contactin-associated protein-like 2 and PRNP, prion protein genes. Overall, 27 SNPs were selected by a tagging approach. FOXP2-rs17213159-C/T resulted associated with disease risk (OR = 2.16, P = 0.0004), as well as with age at onset and severity of dementia. Other FOXP2 markers were associated with semantic and phonological fluency scores, cognitive levels (MMSE) and neuropsychological tests. Associations with language, cognitive and brain atrophy measures were found with CNTNAP2 and PRNP genetic variability. Overall, although preliminary, results here presented suggest an influence of regulatory pathways centred on FOXP2 as a molecular background of FTD affecting neurological function of multiple brain areas.

Keywords: CNTNAP2; FOXP2; FTD; Frontotemporal dementia; PRNP; SNPs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. Konopka G., Bomar J.M., Winden K., Coppola G., Jonsson Z.O., Gao F., Peng S., Preuss T.M., Wohlschlegel J.A., Geschwind D.H. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature. 2009;462:213–217. doi: 10.1038/nature08549. - DOI - PMC - PubMed
    1. Spiteri E., Konopka G., Coppola G., Bomar J., Oldham M., Ou J., Vernes S.C., Fisher S.E., Ren B., Geschwind D.H. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am. J. Hum. Genet. 2007;81:1144–1157. doi: 10.1086/522237. - DOI - PMC - PubMed
    1. Fisher S.E., Vargha-Khadem F., Watkins K.E., Monaco A.P., Pembrey M.E. Localisation of a gene implicated in a severe speech and language disorder. Nat. Genet. 1998;18:168–170. doi: 10.1038/ng0298-168. - DOI - PubMed
    1. Morgan A., Fisher S.E., Scheffer I., Hildebrand M. In: GeneReviews® [Internet] Adam M.P., Feldman J., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Amemiya A., editors. University of Washington, Seattle; Seattle (WA): 2016 Jun 23. FOXP2-Related speech and language disorder; pp. 1993–2024. [updated 2023 Jan 26]
    1. Reuter M.S., Riess A., Moog U., Briggs T.A., Chandler K.E., Rauch A., Stampfer M., Steindl K., Gläser D., Joset P., Ddd Study, Krumbiegel M., Rabe H., Schulte-Mattler U., Bauer P., Beck-Wödl S., Kohlhase J., Reis A., Zweier C. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum. J. Med. Genet. 2017;54:64–72. doi: 10.1136/jmedgenet-2016-104094. - DOI - PubMed

LinkOut - more resources